Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
1
pubmed:dateCreated
1997-4-2
pubmed:abstractText
We performed 123I-(S)-2-hydroxy 3-iodo-6-methoxy-N-[(1-ethyl-2-pyrrolidinyl)methyl]benzamide (123I-IBZM)-scintigraphy to evaluate one usefulness of this radiopharmaceutic agent for the diagnosis of malignant melanomas.
pubmed:language
ger
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Jan
pubmed:issn
0029-5566
pubmed:author
pubmed:issnType
Print
pubmed:volume
36
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1-6
pubmed:dateRevised
2007-1-12
pubmed:meshHeading
pubmed:year
1997
pubmed:articleTitle
[Diagnostic value of 123iodine-ibzm scintigraphy for staging of malignant melanomas].
pubmed:affiliation
Funktionsbereich, für Nuklearmedizin, Robert-Rössle-Klinik, Virchow-Klinikum, Humboldt-Universität zu Berlin, Deutschland.
pubmed:publicationType
Journal Article, Comparative Study, English Abstract